DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells

Yuriko Saiki, Yuki Yoshino, Hiroko Fujimura, Tatsuya Manabe, Yuki Kudo, Miki Shimada, Nariyasu Mano, Tomohiro Nakano, Yoonha Lee, Shinjiro Shimizu, Shinya Oba, Sho Fujiwara, Hideyuki Shimizu, Na Chen, Zhaleh Kashkouli Nezhad, Guo Jin, Shinichi Fukushige, Makoto Sunamura, Masaharu Ishida, Fuyuhiko MotoiShinichi Egawa, Michiaki Unno, Akira Horii

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Fingerprint Dive into the research topics of 'DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds